DCK and acute lymphoblastic leukemia: In the present study, to verify the involvement of DCK in the antileukemic activity of Ara‐C against BCP‐ALL, we knocked out DCK expression in an Ara‐C‐sensitive cell line using the CRISPR‐Cas9 system 14, 15.